Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health


Personal tools

Srivastava, Shiv (Ph.D.)

PI, Center for Prostate Disease Research Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center, 240-453-8952

Contact Information

EDRN Principal Investigator
prostate cancer

To update contact information, please visit the Data Management and Coordinating Center.

Open Protocols

None Available.

Closed Protocols

Protocol Name Biomarkers Datasets
SELDI Phase I: Assay Validation-Prostate 0 1
SELDI Validation Study Phase II 0 3


Publication Name PubMed ID Journal
Predicting Prostate Cancer Progression as a Function of ETS-related Gene Status, Race, and Obesity in a Longitudinal Patient Cohort. 28753864 Eur Urol Focus
Differences in frequency of ERG oncoprotein expression between index tumors of Caucasian and African American patients with prostate cancer. 22950997 Urology
Low Frequency of the ERG Oncogene Alterations in Prostate Cancer Patients from India. 23901346 J Cancer
Predominance of ERG-negative high-grade prostate cancers in African American men. 25279185 Mol Clin Oncol
Clinical potential of the ERG oncoprotein in prostate cancer. 22331093 Nat Rev Urol
Functional antagonism of TMPRSS2-ERG splice variants in prostate cancer. 25221645 Genes Cancer
A novel genomic alteration of LSAMP associates with aggressive prostate cancer in African American men. 26844274 EBioMedicine
Increased association of the ERG oncoprotein expression in advanced stages of prostate cancer in Filipinos. 24909781 Prostate
ERG monoclonal antibody in the diagnosis and biological stratification of prostate cancer: delineation of minimal epitope, critical residues for binding, and molecular basis of specificity. 25170998 Monoclon Antib Immunodiagn Immunother
Genetic and molecular differences in prostate carcinogenesis between African American and Caucasian American men. 23892597 Int J Mol Sci
Ethnicity and ERG frequency in prostate cancer. 28872154 Nat Rev Urol
ERG protein expression and genomic rearrangement status in primary and metastatic prostate cancer--a comparative study of two monoclonal antibodies. 22231490 Prostate Cancer Prostatic Dis.
ERG oncoprotein expression in prostate carcinoma patients of different ethnicities. 25469265 Mol Clin Oncol
Analytical platform evaluation for quantification of ERG in prostate cancer using protein and mRNA detection methods. 25889691 J Transl Med
Autoantibodies against oncogenic ERG protein in prostate cancer: potential use in diagnosis and prognosis in a panel with C-MYC, AMACR and HERV-K Gag. 28191285 Genes Cancer
ERG oncoprotein inhibits ANXA2 expression and function in prostate cancer. 25344575 Mol. Cancer Res.

To update protocols, publications, biomarkers, or science data, please contact the Informatics Center.


Center for Prostate Disease Research 1530 East Jefferson St.
Uniformed Services University of the Health Sciences/Center for Prostate Disease Research

To update addresses, please visit the Data Management and Coordinating Center.

Announcement 03/14/2018
Thank you to everyone to made the 10th EDRN Scientific Workshop a success. The next event is the 33rd EDRN Steering Committee Meeting from September 5-6, 2018 in Boston, MA. Details will be available soon.

Three new FOAs on the Human Tumor Atlas and associated with the Cancer Moonshot Initiative have been released. Please click here for more information.

Announcement 10/23/2017

Three new FOAs on the Human Tumor Atlas and associated with the Cancer Moonshot Initiative have been released. Please click here for more information.

EDRN Founder Honored

Dr. Sudhir Srivastava was honored with the Distinguished Service Award from the American Pancreatic Association at the group's annual meeting this year, for his outstanding commitment to pancreatology.